GL1X · GenesisL1 explorer

MolNFT v1 · #138315 · protein

Agonist bound human A2A adenosine receptor with D52N mutation at 2.60 a resolution

5WF5 · Human A2A adenosine receptor T4L chimera: “Agonist bound human A2A adenosine receptor with D52N mutation at 2.60 a resolution”. X-ray diffraction, 1 ligand (UKA), 5 pockets (best druggability 0.72). MolNFT v1 #138315 on GenesisL1…

PDB
5WF5
Type
protein
Length
444 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Human A2A adenosine receptor T4L chimera
EC
3.2.1.17
UniProt
P29274, P00720
Ligands
UKA
Pockets
5 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 75% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHuman A2A adenosine receptor T4L chimera (EC 3.2.1.17)protein44475% helix, 5% strandP29274, P00720

Ligands and binding sites

  • UKA · 6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl) carbamoylamino]ethyl]purine-2-carboxamide · ligand · chains A
  • OLC · (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12540.720.8628UKA
21850.480.7625empty
3860.380.7620empty
4790.340.7419empty
5770.300.7218empty

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5WF5 · Agonist bound human A2a adenosine receptor with D52N mutation at 2.60 A resolution · the same entry in another collection · chain A against A, TM-score 1.00
  • P29274 · AlphaFold monomer V2.0 prediction for adenosine receptor A2A (P29274) · a predicted model of the same protein · chain A against A, TM-score 0.63

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.